MARKET

PLYGF

PLYGF

PolyPeptide Group
OTCPK
43.00
NaN%
Closed 09:30 06/12 EDT
OPEN
--
PREV CLOSE
43.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
50.00
52 WEEK LOW
31.50
MARKET CAP
1.42B
P/E (TTM)
-57.3257
1D
5D
1M
3M
1Y
5Y
1D
UBS Reaffirms Their Buy Rating on PolyPeptide Group AG (PPGN)
TipRanks · 05/07 09:07
Hims & Hers on track to extend gains as RFK Jr. seeks to loosen peptide regulations
Seeking Alpha · 04/16 09:15
FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides
Seeking Alpha · 04/15 17:42
PolyPeptide Confirms Strategic Review Amid Takeover Speculation
TipRanks · 04/14 05:33
Midday Fly By: Goldman reports Q1 beat, Baker Hughes to sell Waygate
TipRanks · 04/13 16:09
PolyPeptide is attracting takeover interest from EQT, KKR, Bloomberg says
TipRanks · 04/13 10:26
RBC Capital Keeps Their Buy Rating on PolyPeptide Group AG (PPGN)
TipRanks · 04/13 10:10
RBC Capital Sticks to Its Buy Rating for PolyPeptide Group AG (PPGN)
TipRanks · 04/10 07:06
More
About PLYGF
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Webull offers Polypeptide Group AG stock information, including OTCPK: PLYGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLYGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLYGF stock methods without spending real money on the virtual paper trading platform.